Learning Objectives
Upon completion of this activity, participants should be able to:
- Summarize new data on the successes and challenges of antiretroviral scale-up programs in resource-limited settings
- Recount new findings on mortality among patients receiving HAART in resource-limited settings
- Discuss recent data on the use of immunologic and clinical criteria to estimate virologic failure in resource-limited settings
- Describe recent insights on tuberculosis coinfection and prevention in HIV-infected patients, including data on complications associated with Bacillus Calmette-Guérin vaccination in HIV-infected children
- Recall data on HIV prevention in males by circumcision
Topics covered include:
- Project HEART: Role of Decentralization in Antiretroviral Scale-up Program in Sub-Saharan Africa
- Survival Rates Observed With Scale-up of a National HIV Treatment Program in Botswana
- Virologic Outcomes Observed in the Chinese National Antiretroviral Treatment Program
- Early Mortality Reduced by Intensive Management of Patients With Low CD4+ Counts: A Kenyan Pilot Study
- Mortality Among Patients Receiving HAART in the Caribbean and Central and South America
- Use of Immunologic and Clinical Criteria Overestimates Virologic Failure: Haitian Cohort
- Use of Immunologic and Clinical Criteria Permits Accumulation of Extensive Drug Resistance: Malawi Cohort
- Variations in Outcome Indicators Among Major Donor-Supported Treatment Programs
- Complications of Bacillus Calmette-Guérin Vaccination in HIV-Infected Children
- Improved Survival Associated With HAART Use Following Tuberculosis Diagnosis
- Circumcision Associated With Sustained Reduction in HIV Infection Risk